These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38964793)

  • 1. Impact of the first year of COVID-19 vaccination strategy in Brazil: an ecological study.
    Aguilar S; Bastos LSL; Maçaira P; Baião F; Simões P; Cerbino-Neto J; Ranzani O; Hamacher S; Bozza FA
    BMJ Open; 2024 Jul; 14(7):e072314. PubMed ID: 38964793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing New York City's COVID-19 Vaccine Rollout Strategy: A Case for Risk-Informed Distribution.
    Schwalbe N; Nunes MC; Cutland C; Wahl B; Reidpath D
    J Urban Health; 2024 Oct; 101(5):923-933. PubMed ID: 38578336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avoidable COVID-19-related deaths and hospitalizations in Brazil, 2020-2023.
    Kupek E
    Vaccine; 2024 May; 42(15):3437-3444. PubMed ID: 38631953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a COVID-19 Vaccine Campaign and SARS-CoV-2 Infection and Mortality Among Adults Aged 60 Years And Older in a Middle-Income Country.
    Macchia A; Ferrante D; Angeleri P; Biscayart C; Mariani J; Esteban S; Tablado MR; de Quirós FGB
    JAMA Netw Open; 2021 Oct; 4(10):e2130800. PubMed ID: 34714342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct impact of COVID-19 vaccination in Chile: averted cases, hospitalizations, ICU admissions, and deaths.
    Brault A; Hart A; Uribe P; Prado J; San Martín J; Maass A; Canals M
    BMC Infect Dis; 2024 May; 24(1):467. PubMed ID: 38698324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The COVID-19 pandemic in Brazil: space-time approach of cases, deaths, and vaccination coverage (February 2020 - April 2024).
    Berra TZ; Alves YM; Popolin MAP; da Costa FBP; Tavares RBV; Tártaro AF; Moura HSD; Ferezin LP; de Campos MCT; Ribeiro NM; Teibo TKA; Rosa RJ; Arcêncio RA
    BMC Infect Dis; 2024 Jul; 24(1):704. PubMed ID: 39026177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021.
    Steele MK; Couture A; Reed C; Iuliano D; Whitaker M; Fast H; Hall AJ; MacNeil A; Cadwell B; Marks KJ; Silk BJ
    JAMA Netw Open; 2022 Jul; 5(7):e2220385. PubMed ID: 35793085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths: insights from the first 2 years of COVID-19 epidemic in Iran.
    Ghafari M; Hosseinpour S; Rezaee-Zavareh MS; Dascalu S; Rostamian S; Aramesh K; Madani K; Kordasti S
    BMC Med; 2023 Nov; 21(1):429. PubMed ID: 37953291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study.
    Jentsch PC; Anand M; Bauch CT
    Lancet Infect Dis; 2021 Aug; 21(8):1097-1106. PubMed ID: 33811817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of COVID-19 childhood and adolescent vaccination on mortality in Argentina.
    Quiroga R; Gastellu S; Fernández B; Ottaviani R; Zuccoli JR; Vallecorsa PD; Aliaga J; Barberia L
    Vaccine; 2024 Sep; 42(22):126037. PubMed ID: 38871572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of quality-adjusted life years on evaluating COVID-19 mitigation strategies: lessons from age-specific vaccination roll-out and variants of concern in Belgium (2020-2022).
    Willem L; Abrams S; Franco N; Coletti P; Libin PJK; Wambua J; Couvreur S; André E; Wenseleers T; Mao Z; Torneri A; Faes C; Beutels P; Hens N
    BMC Public Health; 2024 Apr; 24(1):1171. PubMed ID: 38671366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.
    Haas EJ; McLaughlin JM; Khan F; Angulo FJ; Anis E; Lipsitch M; Singer SR; Mircus G; Brooks N; Smaja M; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet Infect Dis; 2022 Mar; 22(3):357-366. PubMed ID: 34562375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High vaccine effectiveness against severe COVID-19 outcomes and population preventable fraction during the Omicron era in Luxembourg: A nationwide retrospective risk factor analysis.
    Bejko D; Ernst C; Vergison A; Stranges S; Zeegers MP; Mossong J
    Vaccine; 2024 Sep; 42(22):126011. PubMed ID: 38825555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.
    Katikireddi SV; Cerqueira-Silva T; Vasileiou E; Robertson C; Amele S; Pan J; Taylor B; Boaventura V; Werneck GL; Flores-Ortiz R; Agrawal U; Docherty AB; McCowan C; McMenamin J; Moore E; Ritchie LD; Rudan I; Shah SA; Shi T; Simpson CR; Barreto ML; Oliveira VA; Barral-Netto M; Sheikh A
    Lancet; 2022 Jan; 399(10319):25-35. PubMed ID: 34942103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Adult, Childhood, and Adolescent Vaccination Coverage Among Military and Civilian Families, United States.
    Nguyen KH; Mansfield KA; Xie CY; Corlin L; Niska RW
    Mil Med; 2023 Jul; 188(7-8):e2651-e2660. PubMed ID: 36695337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of High Covid-19 Vaccination Rate in an Aging Population: Estimating Averted Hospitalizations and Deaths in the Basque Country, Spain Using Counterfactual Modeling.
    Estadilla CDS; Mar J; Ibarrondo O; Stollenwerk N; Aguiar M
    J Epidemiol Glob Health; 2024 Sep; 14(3):1289-1299. PubMed ID: 39186212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling optimal vaccination strategies against COVID-19 in a context of Gamma variant predominance in Brazil.
    Ferreira LS; de Almeida GB; Borges ME; Simon LM; Poloni S; Bagattini ÂM; da Rosa MQM; Diniz Filho JAF; Kuchenbecker RS; Camey SA; Kraenkel RA; Coutinho RM; Toscano CM
    Vaccine; 2022 Nov; 40(46):6616-6624. PubMed ID: 36210250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.